Partner Andrew Sharples, the head of EIP Life, will give a talk at a One Nucleus event which focuses on antibody-based therapeutics.
The Life Science Leadership Series event is hosted by the life sciences business network One Nucleus, and takes place at the Babraham Research Campus in Cambridge on 23 January.
Andrew’s talk is entitled ‘Assessing freedom to operate in the antibody-drug conjugation (ADC) arena’. Click here for the full programme.
The One Nucleus Leadership Series features one-day events that focus by therapeutic or technology area, and include a programme of presentations, partnering and networking opportunities for the life sciences community.